ORIC Pharmaceuticals, Inc.
ORIC
$12.05
-$0.17-1.39%
NASDAQ
| 12/31/2025 | 09/30/2025 | 06/30/2025 | 03/31/2025 | 12/31/2024 | |
|---|---|---|---|---|---|
| Net Income | -30.51M | -32.59M | -36.36M | -30.02M | -36.31M |
| Total Depreciation and Amortization | 320.00K | 288.00K | 310.00K | 302.00K | 304.00K |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | 6.04M | 5.04M | 5.98M | 5.67M | 3.57M |
| Change in Net Operating Assets | 1.66M | 2.14M | -780.00K | -8.49M | 4.38M |
| Cash from Operations | -22.48M | -25.11M | -30.84M | -32.53M | -28.05M |
| Capital Expenditure | -227.00K | -35.00K | -63.00K | -387.00K | -219.00K |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | 17.21M | -110.50M | -76.87M | 22.84M | 42.87M |
| Cash from Investing | 16.98M | -110.54M | -76.93M | 22.45M | 42.66M |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | -- | -- | -- | -- | -- |
| Issuance of Common Stock | 1.50M | 111.19M | 134.72M | 253.00K | 575.00K |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | 0.00 | -1.74M | -414.00K | -242.00K | 0.00 |
| Cash from Financing | 1.50M | 109.45M | 134.30M | 11.00K | 575.00K |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | -4.00M | -26.20M | 26.53M | -10.07M | 15.18M |